Labiana Health, S.A. (BME:LAB)

Spain flag Spain · Delayed Price · Currency is EUR
4.700
0.00 (0.00%)
At close: Jan 16, 2026
62.07%
Market Cap32.88M
Revenue (ttm)71.67M
Net Income (ttm)904.36K
Shares Out7.00M
EPS (ttm)0.13
PE Ratio36.35
Forward PE13.04
Dividendn/a
Ex-Dividend Daten/a
Volume348
Average Volume1,459
Open4.700
Previous Close4.700
Day's Range4.700 - 4.760
52-Week Range2.620 - 4.900
Beta0.21
RSI51.04
Earnings DateApr 22, 2026

About Labiana Health

Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, North America, rest of European Union, and internationally. The company offers anesthetics-sedative, anti-infective, anti-inflammatory, antiparasitic, hormonal, and nutritional products; metabolism regulators; and vitamin products. It also provides sterile, lyophilized dosage forms, bacterial vaccines and biological formats; and Fosfomycin trometamol under the Fosfomicina Labiana brand name. In addition, the company offers contrac... [Read more]

Sector Healthcare
Founded 1958
Employees 369
Stock Exchange Madrid Stock Exchange
Ticker Symbol LAB
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.